DDJ Patient Article · As of March 2026 · Explained Simply
When is a sinus lift truly justified, and when do short implants offer the same treatment logic with less morbidity?
Explained in an easy-to-understand way based on current scientific studies. This article helps you make informed decisions with your dentist.
This article is about a treatment your dentist may recommend or perform.
Quick Summary
The most important findings at a glance:
- Research overall shows a benefit.
- The scientific basis is strong. Several high-quality studies arrive at similar results.
- Short implants can be a genuine alternative in suitable situations.
- When two paths achieve similar goals, the more invasive path requires further explanation.
Why is this topic important for you?
You may have heard that there are differing opinions on this topic. This is because science is often more complex than a simple yes or no answer suggests. In this article, we explain what current research actually shows—without technical jargon and without omitting important details.
This topic involves a balance of indication and load, not just a reflex action for augmentation.
Why is this important for you? Because as a patient, you can make better decisions when you understand the background information. This article does not replace a conversation with your dentist, but it gives you the knowledge to ask the right questions.
In research, the most important questions revolve around the following areas: anatomical necessity, survival versus morbidity, and patient and case selection. Below, we explain what each of these areas says according to studies and what that means for your daily life.
What does "anatomical necessity" mean for me as a patient?
A common patient question is how to weigh anatomical necessity. The answer is not as simple as one might hope—but research now provides clear indications.
The central question of this topic cluster is: At what level of residual bone height in the posterior maxilla is a sinus lift truly anatomically necessary, and when is a short implant sufficient? Several systematic reviews and summaries of multiple studies from recent years have addressed this threshold. Fan et al. (2017), who summarized multiple studies including only RCTs, compared short implants (5–8 mm) directly with longer implants (>8 mm) plus a sinus lift in atrophic posterior maxillae. The pooled results showed no statistically significant difference in implant survival rate between the two groups. Toledano et al. (2022) confirmed this pattern in their own systematic review summarizing multiple studies, reporting a Risk Ratio of 1.02 for the survival rate of short versus standard implants in augmented sites—a signal that suggests clinical equivalence.
A PROSPERO-registered systematic review from 2023 deliberately limited itself to RCTs with at least five years of follow-up and found a survival rate of 95.78% for short implants compared to 99.5% for standard implants with a sinus lift in 203 patients with 393 implants. The Risk Ratio for implant survival rate was 0.97, with low heterogeneity (I² = 0%). This means the difference is statistically below the threshold of significance, although the numerical trend slightly favors standard implants.
The most recent and comprehensive study (2025) analyzed 7 RCTs with 282 patients and 477 implants at follow-up times of five years or more. The overall Risk Ratio for success/survival was 2.37, with the wide statistical confidence interval indicating high uncertainty. In the subgroup analysis comparing success definition versus survival definition, the effect estimate was 2.01 without statistical heterogeneity (I² = 0.00%). These data show: Even with long-term follow-up, there is no conclusive evidence that standard implants with a sinus lift are clearly superior to short implants in terms of survival rate.
Even an independent systematic review by Esposito et al. (2010), based on 10 RCTs, found that short implants (5 mm) could be successfully loaded at a residual bone height of 4–6 mm, but the long-term outcome remained unclear. At that time, it was also shown that for 3–6 mm of remaining bone height, a crestal approach with 8-mm implants caused fewer complications than a lateral window approach with implants of at least 10 mm length. These findings provide historical context: As early as over 15 years ago, it was suggested that not every reduced bone height automatically requires an invasive sinus lift.
Taken together, a consistent picture emerges across multiple systematic reviews: For moderate atrophy (residual bone height of about 4–8 mm), short implants are an equivalent alternative to the sinus lift with standard implants when measured by survival rates over up to seven years. Therefore, the anatomical threshold at which augmentation is truly necessary is higher than what clinical routine suggests in many places. It is not the reduced bone height per se, but the combination of extreme atrophy, unfavorable load distribution, and deficient bone quality that makes a sinus lift unavoidable.
Methodologically, it must be noted that the included studies vary significantly in study design, follow-up period, and patient selection. This heterogeneity limits the comparability of the results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different types of studies.
For transferability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence comes from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the core message.
For clinical practice, this means: The indication for a sinus lift should not be reflexively suggested for every reduced bone height but must be anatomically and biomechanically justified. With residual bone height of 4–8 mm in the posterior maxilla, a short implant (5–8 mm) is an evidence-based alternative that shows comparable survival rates in available RCTs.
What the scientific evidence does not show: Equivalent survival rates do not mean that short implants are suitable in every situation. In cases of extreme vertical atrophy (<4 mm), unfavorable bone quality, or high occlusal load, there is a lack of sufficient long-term data for short implants. The prosthetic context—single crown versus fixed partial denture, cemented versus screwed—also influences the decision and is not differentiated in most RCTs.
The clinical decision should be guided by an individual analysis of anatomy and risk, not by a general protocol. When two approaches achieve similar outcomes, the more invasive approach requires further justification. This is where the clinician's responsibility lies: The sinus lift is not obsolete, but it is also not the default.
What does this mean for you? Short implants can be a genuine alternative in appropriate situations.
What does this mean for your next dental appointment? The research findings help you better understand your dentist's recommendations and ask specific questions if anything is unclear.
The science has intensively studied this topic in recent years. For this article, more than 7 scientific papers were evaluated. It is important to understand that not every study carries the same weight of evidence. Large, well-controlled studies provide more reliable results than small observational studies. The overall picture from these various studies is what we present here.
💡 What does this mean for you?
Short implants can be a genuine alternative in appropriate situations. Discuss with your dentist at your next visit what this means specifically for your situation.
Survival vs. Morbidity: Which is Better?
When comparing survival versus morbidity, the research situation is clearer than many people think. Here is what current studies actually show.
Survival rate is the most frequently reported primary endpoint in literature comparing sinus lift versus short implants—and this is where the data shows consistent equivalence. However, survival alone does not provide a complete picture. A meta-analysis of several studies from 2023 specifically examined secondary endpoints with follow-up for at least five years. Regarding marginal bone loss (MBL), a significant difference was found: the weighted mean difference was −0.29 mm in favor of short implants, although there was high heterogeneity (I² = 64 %). Standard implants with sinus lift showed more periimplant bone loss over five years. Toledano et al. (2022) reported a similar finding with an MBL difference of 0.23 mm favoring short implants.
The most recent meta-analysis (2025) confirmed this trend: marginal bone loss was significantly lower with short implants than with long implants requiring a sinus lift, with statistical significance even after FDR correction (adjusted p = 0.03). The heterogeneity was moderate (I² = 33.11 %). MBL values ranged from 0.12 mm to 1.52 mm in the short implant group and from 0.14 mm to 1.85 mm in the long implant group. These findings are clinically relevant: reduced bone loss over time can positively influence the long-term prognosis of the periimplant tissues and, consequently, implant health.
In addition to marginal bone loss, the two treatment options differ significantly in surgical morbidity. The sinus lift—especially via lateral window access—carries specific complication risks: perforation of the Schneiderian membrane, sinusitis, graft failure, postoperative pain, swelling, and, in rare cases, implant migration into the maxillary sinus. A PROSPERO-registered meta-analysis of several studies showed a risk ratio of 0.46 for biological complications, indicating significantly fewer biological complications with short implants. However, no significant difference was found regarding prosthetic complications (RR 1.51; 95% CI: 0.64–3.55; p = 0.34).
A meta-analysis from 2025 confirmed that short implants do not carry a higher complication risk: the risk ratio for complications was 0.88 without heterogeneity (I² = 0.00 %). A prospective study cited in this meta-analysis documented patient morbidity after sinus lift using a visual analog scale: moderate pain in the first two days (Median = 5/10), decreasing by day five, swelling in 97.36 % of patients, and ecchymosis in 51.32 % of patients. This surgical burden must be weighed against the marginal survival advantage.
An independent scientific meta-analysis by Esposito et al. (2010) already found that for a residual bone height of 3–6 mm, crestal access with 8-mm implants caused fewer complications than lateral window access with long implants. This supports the argument that the type of access itself—and not just implant length—contributes to morbidity. Healing dynamics also play a role: a single-stage approach with short implants significantly shortens treatment time compared to a two-stage sinus lift protocol, which is relevant for patients with limited compliance or systemic risk factors.
Methodologically, it should be noted that the included studies vary considerably in study design, follow-up period, and population selection. This heterogeneity limits the comparability of results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different study types.
For transferability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence originates from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the core statement.
If two treatment paths achieve comparable survival rates, morbidity becomes the main clinical argument. The scientific evidence consistently shows that short implants cause fewer biological complications (RR 0.46) and less marginal bone loss (Difference 0.23–0.29 mm) than standard implants with a sinus lift. The sinus lift adds an extra surgical step to the treatment pathway, which is associated with relevant postoperative morbidity.
What this does not imply: This data is not an argument against the sinus lift per se. It is an argument against automaticity. In situations where a short implant is anatomically and prosthetically viable, the added value of the sinus lift must be actively justified. The traditional paradigm—more bone is always better—is not supported by long-term data when the alternative provides comparable outcomes with less invasiveness.
For patient communication, this means: The risk-benefit assessment between a sinus lift and a short implant should be conducted transparently. Treatment time, postoperative burden, cost, and complication risk are relevant decision parameters that the patient needs to know. The decision for the more invasive route should be anatomically justified, not habitual.
What does this mean for you? Short implants often simplify the procedure pathway.
What does this mean for your next dental appointment? The research findings help you better contextualize your dentist's recommendations and ask targeted questions if anything is unclear.
How do scientists arrive at these conclusions? They don't just evaluate a single study; they look at many studies simultaneously. This allows them to determine whether a result was random or if it is consistently confirmed. In this case, the findings are based on 7 scientific papers from different countries and research groups.
💡 What does this mean for you?
Short implants often simplify the procedure pathway. Discuss with your dentist at your next visit what this specifically means for your situation.
What Does "Patient and Case Selection" Mean for Me as a Patient?
One point that often causes confusion is patient and case selection. However, science has made important progress in recent years.
The third cluster addresses a question that is often overlooked in the literature: What patient and case factors determine whether a short implant or a sinus lift with a standard implant is the more clinically appropriate approach? Summaries of multiple studies provide average values, but the posterior maxilla is not a uniform scenario. The current research shows relevant limitations here: A summary of multiple studies from 2025 explicitly states that subgroup analyses based on patient factors could not be performed in any of the seven included RCTs because the necessary data were not reported in detail. In one study, 25% of patients in the long implant group were smokers, but only 5% in the short implant group—an imbalance that can distort the assessment of efficacy.
Soft tissue thickness is another factor increasingly discussed in the literature as prognostically relevant. Linkevicius and colleagues showed that a vertical soft tissue thickness of at least 3 mm was associated with crestal bone stability around implants. This could be particularly relevant for short implants: With less available bone, soft tissue coverage against bacterial infiltration and peri-implant disease gains importance. However, only one of the included studies reported on clinically relevant soft tissue parameters such as keratinized tissue height and soft tissue thickness.
Prosthetic planning significantly influences case selection. Most included RCTs used cemented single crowns as the final restoration. Only one study also included screwed crowns. Therefore, the question of whether short implants perform equally well in blocked restorations, bridges, or under higher occlusal load remains open. A summary of multiple studies from 2023 notes that prosthetic complications were not significantly different (RR 1.51; p = 0.34), but the variability of results could be explained by differences in edentulism type, prosthetic loading, and restoration type.
Patient acceptance and selection play a clinically underestimated role. A summary of multiple studies from 2025 explicitly discusses social determinants of health as an influencing factor: Patients with lower socioeconomic status showed a higher risk of implant failure in a cited case-control study, which was attributed to limited follow-up care options. For geriatric patients with systemic underlying diseases, a single short implant approach could be beneficial because it requires fewer procedures and reduces the healing burden. Patients with pronounced dental anxiety or phobia could also benefit from a less invasive option.
The role of surgeon experience is increasingly recognized in the literature as an independent selection factor. Surgical skill and experience limit the applicability of augmentation procedures, while short implants potentially lower the surgical requirement profile. A summary of multiple studies from 2025 emphasizes the need for standardized surgeon training and calibration protocols, as six of the seven studies were multicenter, and interoperator variability could influence outcome measurement. Prosthetically-driven implantation with CBCT-guided planning is discussed as a way to reduce this variability—regardless of whether short or long implants are chosen.
Methodologically, it must be noted that the included studies vary considerably in study design, follow-up period, and population selection. This heterogeneity limits the comparability of results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different types of studies.
For transferability to the German-speaking care context, it is also relevant that a large portion of the scientific evidence comes from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the core statement.
For practice, this means: The decision between a sinus lift and a short implant is not a binary choice but a selection process. Age, systemic health, smoking status, soft tissue phenotype, bone quality, prosthetic treatment concept, patient preference, and surgeon experience are clinically relevant variables that must be factored into the decision. The scientific evidence provides direction, but not an algorithm.
What the scientific evidence does not support: A general switch from sinus lifts to short implants is no more evidence-based than the traditional preference for a sinus lift. The point is not that one method is better, but that the indication must be set more precisely. For a systemically healthy non-smoker with 5 mm of residual bone height and favorable bone quality, the data support a short implant. For a patient with 2 mm of residual height, bruxism, and high occlusal load, the sinus lift remains indicated.
The best treatment decision does not come from dogma but from a systematic analysis of anatomy, risk, and load. The current body of literature shows that both approaches yield comparable results with proper selection—and that incorrect selection can be problematic in both directions.
What does this mean for you? Case selection determines whether simplification or augmentation is more plausible.
What does this mean for your next dental appointment? The research findings help you better contextualize your dentist's recommendations and ask targeted questions if anything is unclear.
What makes these results reliable? In medical research, the rule is: the more independent studies that arrive at the same result, the more certain the statement is. The type of study and the number of participants also play an important role. Large controlled studies with many participants provide more reliable results than small surveys.
💡 What does this mean for you?
Case selection determines whether simplification or augmentation is more plausible. Discuss with your dentist at your next visit what this specifically means for your situation.
Frequently Asked Questions
Here we answer the questions patients most frequently ask about this topic:
❓ What does "anatomical necessity" mean for me as a patient?
Short implants can be a real alternative in suitable situations.
❓ What matters more: survival or morbidity?
Short implants often reduce the surgical procedure.
❓ What does "patient and case selection" mean for me as a patient?
Case selection determines whether simplification or augmentation is more plausible.
❓ How certain are the results?
The scientific basis is strong. Multiple high-quality studies arrive at similar results.
❓ Should I change my behavior based on this information?
Talk to your dentist before making any changes. This article informs you about the state of research, but every situation is individual. Your dentist knows your personal health status best.
❓ Where can I learn more?
The full professional version of this article with all study details can be found on Daily Dental Journal. For a personal consultation, please see your dentist.
❓ What is the main message of this article?
Short implants must be considered as a real alternative, not just as a last resort.
❓ Why are there differing opinions on this topic?
The dispute is less about the fundamental feasibility of both approaches and more about the threshold at which augmentation becomes too aggressive.
🦷 When Should You See a Dentist?
Schedule an appointment with your dentist if:
- You are unsure if a recommended treatment is appropriate for you
- You have symptoms or notice any changes
- You would like to get a second opinion
- You have questions about the topics described in this article
- It has been more than a year since your last dental visit
Important: This article does not replace a dental visit. It helps you go into the conversation informed.
What You Can Do Yourself
Here are concrete steps you can take as a patient:
The Most Important Takeaway in One Sentence
When two approaches achieve similar goals, the more invasive approach requires further explanation.
Source Information
This article is based on current scientific evidence and the DDJ editorial guidelines. All statements are supported by studies and presented in a way that is understandable for patients.
The content was prepared by the DDJ editorial team for patients. Medical decisions should always be made in consultation with your dentist.
Date: March 2026 · Language: American English (en-US) · Target Audience: Patients and interested laypeople